TOP TIERMARKET NEWSWIRE
News & sentiment

BIOCRYST PHARMACEUTI (BCRX) — News & AI sentiment

BIOCRYST PHARMACEUTI (BCRX) news roundup. 8 stories in the past week, 17 over 30 days. Average 30-day sentiment is 57.6/100. No insider transactions filed in the last 90 days. US House Periodic Transaction Reports (90-day window): 2 purchases (~$16K) and 0 sales (~$0). Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
8
avg sentiment 51.3/100
30d stories
17
avg sentiment 57.6/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
2
2 buys · 0 sells

BCRX news in the last 24 hours, 7 days, 30 days and 90 days

How much BCRX coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowBCRX storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days851.3/100BCRX headlines →
Last 30 days1757.6/100BCRX headlines →
Last 90 days4158.6/100BCRX headlines →

Latest stories on BCRX

2d ago
3d ago
3d ago
4d ago
5d ago
5d ago
5d ago
TD Cowen initiates BioCryst stock with buy rating on HAE drug outlook
Investing.com Analyst Ratings61 · neutralanalyst
5d ago
Sep 6
BioCryst to Present at Upcoming Investor Conference
Business Insider56 · neutralgeneral
Sep 1
Sep 1
Aug 28
Aug 28
Aug 28
Aug 28
Aug 25
Aug 25
Aug 12
BioCryst (BCRX) Q2 2026 Earnings Call Transcript
The Motley Fool67 · bullishearnings
Aug 12
Aug 11
Aug 6
Aug 5
Aug 5
Aug 5
Aug 5
Open BCRX in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →